Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status

التفاصيل البيبلوغرافية
العنوان: Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
المؤلفون: Teesha Downton, Fiona Zhou, Davendra Segara, Rinath Jeselsohn, Elgene Lim
المصدر: Drug Design, Development and Therapy. 16:2933-2948
بيانات النشر: Informa UK Limited, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Selective Estrogen Receptor Modulators, Pharmacology, Receptors, Estrogen, Drug Discovery, Estrogen Receptor alpha, Humans, Pharmaceutical Science, Breast Neoplasms, Female, Mouth Neoplasms, Breast
الوصف: Several endocrine therapies are currently available for the treatment of estrogen receptor (ER) positive breast cancer, but the clinical benefit of these agents is limited by endocrine therapy drug resistance. A common mechanism of endocrine therapy resistance is
تدمد: 1177-8881
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0b9d02ddff2da711df5013229cc4876Test
https://doi.org/10.2147/dddt.s380925Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....a0b9d02ddff2da711df5013229cc4876
قاعدة البيانات: OpenAIRE